comparemela.com
  1. Home
  2. Live Updates
  3. Call Link - Breaking News

Page 3 - Call Link News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Longboard Pharmaceuticals Announces Positive Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial, for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)

Bexicaserin achieved a median seizure reduction of 53.3% in countable motor seizures compared to 20.8% in the placebo group across the DEE study population A median seizure reduction of 72.1% in.

United statesRandall kayeEncephalopathies deesTracy dixon salazarKevinr lindDennis dlugosEpilepsy study consortiumLongboard pharmaceuticals incExchange commissionLongboard pharmaceuticalsEpileptic encephalopathiesTopline resultsEfficacy dataSafety dataChief medicalExecutive director

Longboard Pharmaceuticals (LBPH) Reports Positive Topline Data from the PACIFIC Study

Longboard Pharmaceuticals (LBPH) Reports Positive Topline Data from the PACIFIC Study
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesEncephalopathies deesDennis dlugosRandall kayeTracy dixon salazarKevinr lindLongboard pharmaceuticals incEpilepsy study consortiumLongboard pharmaceuticalsEpileptic encephalopathiesTopline resultsEfficacy dataSafety dataChief medicalExecutive directorVice president

Longboard Pharmaceuticals to Host Call to Discuss Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)

• Conference call and webcast to be held tomorrow, January 2, at 8:30am ET .

Encephalopathies deesExchange commissionLongboard pharmaceuticals incLongboard pharmaceuticalsEpileptic encephalopathiesWebcast linkCall linkPrivate securities litigation reform actMiddle east

Longboard Pharmaceuticals to Host Call to Discuss Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)

Longboard Pharmaceuticals to Host Call to Discuss Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Encephalopathies deesLongboard pharmaceuticals incExchange commissionGhost callDiscuss topline dataClinical trialEpileptic encephalopathiesWebcast linkCall linkPrivate securities litigation reform actMiddle east

Vantage Drilling International Schedules Third Quarter 2023 Earnings Release Date and Conference Call

Vantage Drilling International Schedules Third Quarter 2023 Earnings Release Date and Conference Call
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Cayman islandsUnited statesRafael blattnervantage drilling internationalVantage drilling internationalVantage energy services incDrilling internationalCall linkVantage energy servicesVantage drilling
© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.